Brief: PharmaCyte Biotech files for mixed shelf offering of up to $50 million
13/09/2017 14:28
Sept 13 (Reuters) - Pharmacyte Biotech Inc PMCB.PK
* PharmaCyte Biotech Inc files for mixed shelf offering of
up to $50 million - SEC filing
Source text : (http://bit.ly/2h17gxN)
Further company coverage: PMCB.PK
((Bangalore.newsroom@thomsonreuters.com; ;))
Recent news on Pharmacyte Biotech
See all newsBrief: Pharmacyte Biotech Inc - Increases Stake In Tnf Pharmaceuticals By $3 Million
Brief: PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
Brief: Pharmacyte Biotech Acquires $5 Million Stake In Emerging Women’S Health Innovator Femasys
Brief: Femasys Inc. Secures Additional Financing With Strategic Investment From Investors Led By Pharmacyte Biotech
Brief: Pharmacyte Biotech Announces Final Results Of Tender Offer